Prostate Cancer Treatment Market Report

Global and China Prostate Cancer Treatment Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 28, 2022
  • PAGES：202
  • REPORT CODE：GMM1415883
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Prostate cancer is the most common cancer among men, the key risk factors for prostate cancer development is being old age, genetic, obesity and race.

    This report elaborates on the current development of the Prostate Cancer Treatment industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • GlaxoSmithKline Plc

    • Bristol-Myers Squibb Company

    • Ferring Pharmaceuticals Inc

    • AstraZeneca plc

    • Bayer AG

    • Astellas Pharma Inc

    • Takeda Pharmaceutical Company Ltd

    • Ipsen Pharma

    • Johnson & Johnson

    • F Hoffmann-La Roche AG

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Radiochemotherapy

    • Hormone therapy

    • Targeted therapy

    • Immunotherapy

    • Surgery

    • Other

    Application:

    • Localized prostate cancer

    • Recurrence of prostate cancer after curative treatment

    • Metastatic hormone sensitive prostate cancer (mHSPC)

    • Non metastatic castration resistant prostate cancer (nmCRPC)

    • Metastatic castration resistant prostate cancer (mCRPC)

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Prostate Cancer Treatment Industry Overview

      • 1.1.1 Prostate Cancer Treatment Market Scope and Market Segments

      • 1.1.2 Prostate Cancer Treatment Industry Characteristics

      • 1.1.3 Global and China Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Prostate Cancer Treatment Production Value and Growth Rate (2017-2028)

    • 1.2 Global Prostate Cancer Treatment Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Radiochemotherapy

      • 1.2.2 Hormone therapy

      • 1.2.3 Targeted therapy

      • 1.2.4 Immunotherapy

      • 1.2.5 Surgery

      • 1.2.6 Other

    • 1.3 Global Prostate Cancer Treatment Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Localized prostate cancer

      • 1.3.2 Recurrence of prostate cancer after curative treatment

      • 1.3.3 Metastatic hormone sensitive prostate cancer (mHSPC)

      • 1.3.4 Non metastatic castration resistant prostate cancer (nmCRPC)

      • 1.3.5 Metastatic castration resistant prostate cancer (mCRPC)

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Prostate Cancer Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Prostate Cancer Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Prostate Cancer Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Prostate Cancer Treatment Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Prostate Cancer Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Prostate Cancer Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Prostate Cancer Treatment Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Prostate Cancer Treatment Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Prostate Cancer Treatment Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Prostate Cancer Treatment Industry Porter's Five Forces Model Analysis

      • 2.2.3 Prostate Cancer Treatment Industry PEST Analysis

    • 2.3 Prostate Cancer Treatment Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Prostate Cancer Treatment Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Prostate Cancer Treatment Industry

    Chapter 3 Global and China Prostate Cancer Treatment Market, by Manufacturer

    • 3.1 Global and China Prostate Cancer Treatment Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Prostate Cancer Treatment Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Prostate Cancer Treatment Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Prostate Cancer Treatment Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Prostate Cancer Treatment Market Top 3 Players

    Chapter 4 Global and China Prostate Cancer Treatment Market, by Type (2017-2028)

    • 4.1 Prostate Cancer Treatment Market Trend, by Type

    • 4.2 Global Prostate Cancer Treatment Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Prostate Cancer Treatment Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Prostate Cancer Treatment Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Prostate Cancer Treatment Price Trend, by Type (2017-2028)

    • 4.3 China Prostate Cancer Treatment Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Prostate Cancer Treatment Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Prostate Cancer Treatment Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Prostate Cancer Treatment Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Prostate Cancer Treatment Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Prostate Cancer Treatment Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Prostate Cancer Treatment Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Prostate Cancer Treatment Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Prostate Cancer Treatment Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Prostate Cancer Treatment Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Prostate Cancer Treatment Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Prostate Cancer Treatment Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Prostate Cancer Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Prostate Cancer Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Prostate Cancer Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Prostate Cancer Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Prostate Cancer Treatment Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Prostate Cancer Treatment Market Analysis

    • 7.1 North America Prostate Cancer Treatment Market, by Type

    • 7.2 North America Prostate Cancer Treatment Market, by Application

    • 7.3 North America Prostate Cancer Treatment Market Analysis and Forecast, by Country

      • 7.3.1 United States Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Prostate Cancer Treatment Market Analysis

    • 8.1 Europe Prostate Cancer Treatment Market, by Type

    • 8.2 Europe Prostate Cancer Treatment Market, by Application

    • 8.3 Europe Prostate Cancer Treatment Market Analysis and Forecast, by Country

      • 8.3.1 Germany Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Prostate Cancer Treatment Market Analysis

    • 9.1 APAC Prostate Cancer Treatment Market, by Type

    • 9.2 APAC Prostate Cancer Treatment Market, by Application

    • 9.3 APAC Prostate Cancer Treatment Market Analysis and Forecast, by Country

      • 9.3.1 China Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Prostate Cancer Treatment Market Analysis

    • 10.1 Latin America, Middle East and Africa Prostate Cancer Treatment Market, by Type

    • 10.2 Latin America, Middle East and Africa Prostate Cancer Treatment Market, by Application

    • 10.3 Latin America, Middle East and Africa Prostate Cancer Treatment Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Prostate Cancer Treatment Company Profiles

      • 11.1 GlaxoSmithKline Plc

        • 11.1.1 GlaxoSmithKline Plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 GlaxoSmithKline Plc Prostate Cancer Treatment Product Profiles, Application and Specification

        • 11.1.3 GlaxoSmithKline Plc Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Bristol-Myers Squibb Company

        • 11.2.1 Bristol-Myers Squibb Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Bristol-Myers Squibb Company Prostate Cancer Treatment Product Profiles, Application and Specification

        • 11.2.3 Bristol-Myers Squibb Company Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Ferring Pharmaceuticals Inc

        • 11.3.1 Ferring Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Ferring Pharmaceuticals Inc Prostate Cancer Treatment Product Profiles, Application and Specification

        • 11.3.3 Ferring Pharmaceuticals Inc Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 AstraZeneca plc

        • 11.4.1 AstraZeneca plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 AstraZeneca plc Prostate Cancer Treatment Product Profiles, Application and Specification

        • 11.4.3 AstraZeneca plc Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Bayer AG

        • 11.5.1 Bayer AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Bayer AG Prostate Cancer Treatment Product Profiles, Application and Specification

        • 11.5.3 Bayer AG Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Astellas Pharma Inc

        • 11.6.1 Astellas Pharma Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Astellas Pharma Inc Prostate Cancer Treatment Product Profiles, Application and Specification

        • 11.6.3 Astellas Pharma Inc Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Takeda Pharmaceutical Company Ltd

        • 11.7.1 Takeda Pharmaceutical Company Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Takeda Pharmaceutical Company Ltd Prostate Cancer Treatment Product Profiles, Application and Specification

        • 11.7.3 Takeda Pharmaceutical Company Ltd Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Ipsen Pharma

        • 11.8.1 Ipsen Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Ipsen Pharma Prostate Cancer Treatment Product Profiles, Application and Specification

        • 11.8.3 Ipsen Pharma Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Johnson & Johnson

        • 11.9.1 Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Johnson & Johnson Prostate Cancer Treatment Product Profiles, Application and Specification

        • 11.9.3 Johnson & Johnson Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 F Hoffmann-La Roche AG

        • 11.10.1 F Hoffmann-La Roche AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 F Hoffmann-La Roche AG Prostate Cancer Treatment Product Profiles, Application and Specification

        • 11.10.3 F Hoffmann-La Roche AG Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Prostate Cancer Treatment Industry Investment Prospect and Risk Assessment

    • 12.1 Prostate Cancer Treatment Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Prostate Cancer Treatment Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure China Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Global Prostate Cancer Treatment Production Value and Growth Rate (2017-2028)

    • Figure China Prostate Cancer Treatment Production Value and Growth Rate (2017-2028)

    • Figure Global Prostate Cancer Treatment Market Size and Growth Rate of Radiochemotherapy (2017-2028)

    • Figure Global Prostate Cancer Treatment Market Size and Growth Rate of Hormone therapy (2017-2028)

    • Figure Global Prostate Cancer Treatment Market Size and Growth Rate of Targeted therapy (2017-2028)

    • Figure Global Prostate Cancer Treatment Market Size and Growth Rate of Immunotherapy (2017-2028)

    • Figure Global Prostate Cancer Treatment Market Size and Growth Rate of Surgery (2017-2028)

    • Figure Global Prostate Cancer Treatment Market Size and Growth Rate of Other (2017-2028)

    • Figure Global Prostate Cancer Treatment Market Size and Growth Rate of Localized prostate cancer (2017-2028)

    • Figure Global Prostate Cancer Treatment Market Size and Growth Rate of Recurrence of prostate cancer after curative treatment (2017-2028)

    • Figure Global Prostate Cancer Treatment Market Size and Growth Rate of Metastatic hormone sensitive prostate cancer (mHSPC) (2017-2028)

    • Figure Global Prostate Cancer Treatment Market Size and Growth Rate of Non metastatic castration resistant prostate cancer (nmCRPC) (2017-2028)

    • Figure Global Prostate Cancer Treatment Market Size and Growth Rate of Metastatic castration resistant prostate cancer (mCRPC) (2017-2028)

    • Figure North America Prostate Cancer Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Prostate Cancer Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Prostate Cancer Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Prostate Cancer Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Prostate Cancer Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Prostate Cancer Treatment Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Prostate Cancer Treatment Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Prostate Cancer Treatment Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Prostate Cancer Treatment Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Prostate Cancer Treatment Market Share, by Manufacturer in 2021

    • Figure Global and China Prostate Cancer Treatment Market Share, by Manufacturer in 2022

    • Table Global Prostate Cancer Treatment Sales Volume, by Type (2017-2028)

    • Table Global Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Global Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Table Global Prostate Cancer Treatment Sales Value, by Type (2017-2028)

    • Table Global Prostate Cancer Treatment Sales Value Share, by Type (2017-2028)

    • Figure Global Prostate Cancer Treatment Price Trend, by Type (2017-2028)

    • Table China Prostate Cancer Treatment Sales Volume, by Type (2017-2028)

    • Table China Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Figure China Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Table China Prostate Cancer Treatment Sales Value, by Type (2017-2028)

    • Table China Prostate Cancer Treatment Sales Value Share, by Type (2017-2028)

    • Figure China Prostate Cancer Treatment Price Trend, by Type (2017-2028)

    • Table Global Prostate Cancer Treatment Sales Volume, by Application (2017-2028)

    • Table Global Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Global Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Table Global Prostate Cancer Treatment Sales Value, by Application (2017-2028)

    • Table Global Prostate Cancer Treatment Sales Value Share, by Application (2017-2028)

    • Figure Global Prostate Cancer Treatment Sales Value Share, by Application (2017-2028)

    • Table China Prostate Cancer Treatment Sales Volume, by Application (2017-2028)

    • Table China Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Figure China Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Table China Prostate Cancer Treatment Sales Value, by Application (2017-2028)

    • Table China Prostate Cancer Treatment Sales Value Share, by Application (2017-2028)

    • Figure China Prostate Cancer Treatment Sales Value Share, by Application (2017-2028)

    • Figure China Prostate Cancer Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure North America Prostate Cancer Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Prostate Cancer Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Prostate Cancer Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Prostate Cancer Treatment Production, Import, Consumption and Export (2017-2022)

    • Table North America Prostate Cancer Treatment Sales Volume, by Type (2017-2028)

    • Table North America Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Figure North America Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Table North America Prostate Cancer Treatment Sales Volume, by Application (2017-2028)

    • Table North America Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Figure North America Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Figure United States Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure United States Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Canada Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Table Europe Prostate Cancer Treatment Sales Volume, by Type (2017-2028)

    • Table Europe Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Europe Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Table Europe Prostate Cancer Treatment Sales Volume, by Application (2017-2028)

    • Table Europe Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Europe Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Germany Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure UK Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure UK Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure France Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure France Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Italy Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Spain Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Poland Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Russia Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Table APAC Prostate Cancer Treatment Sales Volume, by Type (2017-2028)

    • Table APAC Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Figure APAC Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Table APAC Prostate Cancer Treatment Sales Volume, by Application (2017-2028)

    • Table APAC Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Figure APAC Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Figure China Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure China Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Japan Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure India Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure India Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Prostate Cancer Treatment Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Prostate Cancer Treatment Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Table GlaxoSmithKline Plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline Plc Product Profiles, Application and Specification

    • Table GlaxoSmithKline Plc Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bristol-Myers Squibb Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bristol-Myers Squibb Company Product Profiles, Application and Specification

    • Table Bristol-Myers Squibb Company Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ferring Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ferring Pharmaceuticals Inc Product Profiles, Application and Specification

    • Table Ferring Pharmaceuticals Inc Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AstraZeneca plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AstraZeneca plc Product Profiles, Application and Specification

    • Table AstraZeneca plc Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bayer AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bayer AG Product Profiles, Application and Specification

    • Table Bayer AG Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Astellas Pharma Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Astellas Pharma Inc Product Profiles, Application and Specification

    • Table Astellas Pharma Inc Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Takeda Pharmaceutical Company Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Takeda Pharmaceutical Company Ltd Product Profiles, Application and Specification

    • Table Takeda Pharmaceutical Company Ltd Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ipsen Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ipsen Pharma Product Profiles, Application and Specification

    • Table Ipsen Pharma Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Johnson & Johnson Product Profiles, Application and Specification

    • Table Johnson & Johnson Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table F Hoffmann-La Roche AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table F Hoffmann-La Roche AG Product Profiles, Application and Specification

    • Table F Hoffmann-La Roche AG Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US